Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for targeted antibody therapy of cancer. [electronic resource]
Producer: 20140421Description: e70332 p. digitalISSN:- 1932-6203
- Animals
- Antibodies, Monoclonal -- immunology
- Antibodies, Monoclonal, Humanized -- genetics
- Antibody Specificity -- immunology
- Antibody-Dependent Cell Cytotoxicity -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Complement System Proteins -- immunology
- Female
- Flow Cytometry
- Humans
- Immunohistochemistry
- Kinetics
- Mice
- Neoplasms -- drug therapy
- Ovarian Neoplasms -- drug therapy
- Protein Binding -- immunology
- Sodium-Phosphate Cotransporter Proteins, Type IIb -- antagonists & inhibitors
- Surface Plasmon Resonance
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.